Tata India Pharma & HealthCare Fund

The scheme seeks long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Growthvine rating: 3/5 — ranked #34 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹33.54 (as of 2026-11-13)
AUM₹1,511 Cr
Expense ratio1.81%
RiskometerVery High
Fund managerRajat Srivastava
Exit load0.25% for redemption within 30 days

Performance & risk

5-year annualised return13.00%
Sharpe ratio0.74
Standard deviation16.53%
Max drawdown−21.94%
Alpha-4.64
Beta1

Over 5 years, captured 91.1% of NIFTY Pharma's upside and 98.4% of its downside.

Market cap allocation

Large cap26.8%
Mid cap30.5%
Small cap42.7%

Concentration

Top 5 holdings29.3%
Top 10 holdings50.1%
Total holdings39

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)11.0%Q2#21 of 76
2025−4.9%Q4 (Bottom)#56 of 69
202440.4%Q1 (Top)#9 of 58
202336.6%Q3#25 of 48
2022−8.0%Q3#35 of 46